“…Recent studies from single tertiary care centers have reported improved survival ranging from 82% to 93% with management strategies emphasizing inhaled nitric oxide, permissive hypercapnea, high frequency oscillatory ventilation, selective use of extracorporeal membrane oxygenation (ECMO), delayed surgical repair, and treatment at high volume centers [11][12][13][14][15][16]. In contrast, current population-based studies from the United Kingdom and Australia report significantly lower survival (54%-56%) of live-born infants despite new therapies for CDH [4,17,18].…”